CTSG and hepatocellular carcinoma: In hepatocellular carcinoma, NET-derived cathepsin G (CTSG) promotes tumor cell invasion by regulating adhesion molecules and inflammatory mediators, a process that can be disrupted by DNAzyme I therapy, indicating its therapeutic potential [126–128].